Pixyl.Neuro.BV
General Information
Product name
Pixyl.Neuro.BV
Company
Subspeciality
Neuro
Modality
MR
Disease targeted
Neurodegenerative diseases, dementia, Alzheimer’s disease, Multiple Sclerosis, Parkinson’s disease
Main task
Not specified
Technical Specifications
Population
patients with known or suspected neurodegenerative disease
Patient population age
Not specified
Input
MR sequence, 3D T1-weighted image
Input format
DICOM
Output
structured quantitative report, table of quantified values, comparison with normative values, graphs of volume evolution with respect to normative values, brain MRI representative screenshots, longitudinal analysis
Output format
DICOM report, PDF report
Integration
Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment
Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Trigger for analysis
Automatically, Etc., Image upload, On demand, Right after the image acquisition, Triggered by a user through e.g. a button click
Processing time
1 - 10 minutes
Regulatory Information
CE Certification
Pathway:
MDR
Class:
Class IIa
Verified by Health AI Register
FDA Certification
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
10-2019
AI Platforms
Blackford Analysis, GE Healthcare, Incepto, Siemens Healthineers
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Subscription
Based on
Number of analyses, Number of installations
Evidence & Research
No research papers or evidence available for this product.
Source: vendor | First published: Apr 11, 2024 | Last updated: Jul 9, 2025